Bridge to nowhere: A retrospective single-center study on patients using chronic intravenous inotropic support as bridge therapy who do not receive surgical therapy
BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery. We aimed to describe reasons patients “crossover” from CIIS as bridge therapy to palliative therapy, and compar...
Main Authors: | Anirudh Rao, Manavotam Singh, Mansi Maini, Kelley M. Anderson, Nancy A. Crowell, Paul R. Henderson, Sherry S. Gholami, Farooq H. Sheikh, Samer S. Najjar, Hunter Groninger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.918146/full |
Similar Items
-
Long‐term administration of intravenous inotropes in advanced heart failure
by: Piero Gentile, et al.
Published: (2021-10-01) -
Does glucagon have a positive inotropic effect in the human heart?
by: Jesus Hernández-Cascales
Published: (2018-11-01) -
Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
by: David Dobarro, et al.
Published: (2023-04-01) -
Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure
by: Edson Antonio Bregagnollo, et al.
Published: (1999-02-01) -
Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers
by: Luanda Grazette, et al.
Published: (2022-04-01)